<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="opitz" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">opitz</book-part-id>
      <title-group>
        <title>X-Linked Opitz G/BBB Syndrome</title>
        <alt-title alt-title-type="alt-title">Synonyms: Opitz Syndrome, X-Linked; XLOS</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Meroni</surname>
            <given-names>Germana</given-names>
          </name>
          <degrees>PhD</degrees>
          <aff>Cluster in Biomedicine (CBM)<break/>Trieste, Italy</aff>
          <email>germana.meroni@cbm.fvg.it</email>
        </contrib>
      </contrib-group>
      <pub-history>
        <date iso-8601-date="2004-12-17" date-type="created">
          <day>17</day>
          <month>12</month>
          <year>2004</year>
        </date>
        <date iso-8601-date="2011-07-28" date-type="updated">
          <day>28</day>
          <month>7</month>
          <year>2011</year>
        </date>
        <date iso-8601-date="2007-06-20" date-type="revised">
          <day>20</day>
          <month>6</month>
          <year>2007</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="retinoschisis" document-type="chapter">X-Linked Juvenile Retinoschisis</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="epp-xl" document-type="chapter">X-Linked Protoporphyria</related-object>
      <abstract id="opitz.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>X-linked Opitz G/BBB syndrome (XLOS) is a multiple congenital anomaly disorder characterized by facial anomalies (ocular hypertelorism, prominent forehead, widow's peak, broad nasal bridge, anteverted nares), laryngotracheoesophageal defects, and genitourinary abnormalities (hypospadias, cryptorchidism, and hypoplastic/bifid scrotum). Developmental delay and intellectual disability are observed in about 50% of affected males. Cleft lip and/or palate are present in approximately 50% of affected individuals. Other malformations present in fewer than 50% of individuals include congenital heart defects, imperforate or ectopic anus, and midline brain defects (Dandy-Walker malformation and agenesis or hypoplasia of the corpus callosum and/or cerebellar vermis). Wide clinical variability occurs even among members of the same family. Female carriers usually manifest only ocular hypertelorism.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>The diagnosis of X-linked Opitz G/BBB syndrome is established most often by clinical findings. <italic toggle="yes">MID1</italic> is the only gene in which pathogenic variants are currently known to cause X-linked Opitz G/BBB syndrome. Sequence analysis of the coding exons and intron-exon boundaries or scanning for pathogenic variants using various techniques detects deletions, insertions, and missense, nonsense, and splice site variants in 15%-45% of males with clinically diagnosed Opitz G/BBB syndrome. The cohorts tested for <italic toggle="yes">MID1</italic> pathogenic variants often include simplex cases (i.e., individuals with no family history of Opitz G/BBB syndrome), who therefore cannot be determined to have either the X-linked form or the autosomal dominant form. The detection rate is higher in individuals with clear X-linked inheritance.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations</italic>: Management of anomalies by a multidisciplinary team; surgical treatment of medically significant laryngotracheoesophageal malformations; tracheostomy as needed; standard surgical management of hypospadias, cleft lip/palate, imperforate anus, heart defects; speech therapy; neuropsychological and educational support.</p>
          <p><italic toggle="yes">Prevention of secondary complications</italic>: Antireflux measurements to minimize risk of aspiration.</p>
          <p><italic toggle="yes">Surveillance</italic>: Based on the type of malformations present; regular monitoring of hearing for those with cleft lip/palate.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>X-linked Opitz G/BBB syndrome is inherited in an X-linked manner. In a family with more than one affected individual, the mother of an affected male is an obligate carrier. If the mother of an affected male is a carrier, the chance of transmitting the pathogenic variant in each pregnancy is 50%. Sons who inherit the pathogenic variant will be affected; daughters who inherit the pathogenic variant will be carriers and will usually manifest hypertelorism. Mildly affected males who have children will pass the pathogenic variant to all of their daughters and none of their sons. Prenatal testing is possible for pregnancies at risk if the pathogenic variant in the family has been identified.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="opitz.Diagnosis">
        <title>Diagnosis</title>
        <sec id="opitz.Clinical_Diagnosis">
          <title>Clinical Diagnosis</title>
          <p>X-linked Opitz G/BBB syndrome (XLOS) is diagnosed on the basis of clinical findings. The multiple clinical signs show variable expressivity in affected individuals, even within the same family.</p>
          <p>The manifestations of XLOS are classified into major and minor findings based on frequency of occurrence. The clinical diagnosis of XLOS is suspected in males with ocular hypertelorism and at least one other major finding. A family history consistent with X-linked inheritance further supports the diagnosis of XLOS [<xref ref-type="bibr" rid="opitz.REF.robin.1996.305">Robin et al 1996</xref>, <xref ref-type="bibr" rid="opitz.REF.de_falco.2003.222">De Falco et al 2003</xref>, <xref ref-type="bibr" rid="opitz.REF.fontanella.2008.584">Fontanella et al 2008</xref>].</p>
          <p>
            <bold>Major (more frequent) findings</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Ocular hypertelorism and/or telecanthus (found in virtually all affected individuals)</p>
            </list-item>
            <list-item>
              <p>All degrees of hypospadias that, in the most severe form, can be associated with renal malformations (85%-90%)</p>
            </list-item>
            <list-item>
              <p>Laryngotracheoesophageal abnormalities, primarily laryngeal cleft, resulting in swallowing difficulties and respiratory dysfunction (60%-70%)</p>
            </list-item>
          </list>
          <p><bold>Minor findings</bold> (found in &#x0003c;50% of individuals)</p>
          <list list-type="bullet">
            <list-item>
              <p>Intellectual disability and developmental delay</p>
            </list-item>
            <list-item>
              <p>Cleft lip and/or palate</p>
            </list-item>
            <list-item>
              <p>Congenital heart defects including ventricular septal defect (VSD) or atrial septal defect (ASD), persistent left superior vena cava, patent ductus arteriosus</p>
            </list-item>
            <list-item>
              <p>Imperforate or ectopic anus</p>
            </list-item>
            <list-item>
              <p>Midline defects of the brain including agenesis of the corpus callosum and cerebellar vermis agenesis or hypoplasia</p>
            </list-item>
          </list>
        </sec>
        <sec id="opitz.Molecular_Genetic_Testing">
          <title>Molecular Genetic Testing</title>
          <p><bold>Gene.</bold>
<italic toggle="yes">MID1</italic> is the only gene in which pathogenic variants are currently known to cause X-linked Opitz G/BBB syndrome (XLOS) [<xref ref-type="bibr" rid="opitz.REF.quaderi.1997.285">Quaderi et al 1997</xref>].</p>
          <p><bold>Possible evidence for locus heterogeneity.</bold> A percentage of individuals with clinically diagnosed XLOS do not have identifiable pathogenic variants in <italic toggle="yes">MID1</italic>. The low variant detection rate may reflect either genetic heterogeneity (i.e., the presence of other, as-yet unidentified loci associated with XLOS on the X chromosome) or the presence of pathogenic variants in regions of <italic toggle="yes">MID1</italic> (e.g., promoter, introns, 5&#x02019; and 3' UTR) not routinely evaluated.</p>
          <p>
            <bold>Clinical testing</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Sequence analysis.</bold> Sequence analysis of the coding exons and intron-exon boundaries detects small deletions/insertions and pathogenic missense, nonsense, and splice site variants in approximately 25% of males with clinically diagnosed XLOS [<xref ref-type="bibr" rid="opitz.REF.gaudenz.1998.703">Gaudenz et al 1998</xref>, <xref ref-type="bibr" rid="opitz.REF.cox.2000.2553">Cox et al 2000</xref>, <xref ref-type="bibr" rid="opitz.REF.de_falco.2003.222">De Falco et al 2003</xref>, <xref ref-type="bibr" rid="opitz.REF.winter.2003.249">Winter et al 2003</xref>, <xref ref-type="bibr" rid="opitz.REF.pinson.2004.381">Pinson et al 2004</xref>, <xref ref-type="bibr" rid="opitz.REF.so.2005.1">So et al 2005</xref>, <xref ref-type="bibr" rid="opitz.REF.fontanella.2008.584">Fontanella et al 2008</xref>]. Note: Since the X-linked Opitz G/BBB syndrome and autosomal dominant Opitz G/BBB syndrome (see <xref ref-type="sec" rid="opitz.Differential_Diagnosis">Differential Diagnosis</xref>) are clinically indistinguishable, the cohorts tested for <italic toggle="yes">MID1</italic> pathogenic variants often include simplex cases (i.e., single occurrences in a family that cannot be defined as either X-linked or autosomal). In this case the variant detection rate is approximately 15%. The variant detection rate increases (i.e., &#x0003e;50%) when only those individuals with documented X-linked inheritance are tested.</p>
            </list-item>
            <list-item>
              <p><bold>Deletion/duplication analysis.</bold>
<italic toggle="yes">MID1</italic> exon and multiexon deletions and duplications (including three whole-gene deletions) have been reported [<xref ref-type="bibr" rid="opitz.REF.winter.2003.249">Winter et al 2003</xref>, <xref ref-type="bibr" rid="opitz.REF.ferrentino.2007.206">Ferrentino et al 2007</xref>, <xref ref-type="bibr" rid="opitz.REF.fontanella.2008.584">Fontanella et al 2008</xref>].</p>
            </list-item>
          </list>
          <table-wrap id="opitz.T.summary_of_molecular_genetic_tes" position="anchor" orientation="portrait">
            <label>Table 1. </label>
            <caption>
              <p>Summary of Molecular Genetic Testing Used in X-Linked Opitz G/BBB Syndrome</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_opitz.T.summary_of_molecular_genetic_tes_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene&#x000a0;<sup>1</sup></th>
                  <th id="hd_h_opitz.T.summary_of_molecular_genetic_tes_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Test Method</th>
                  <th id="hd_h_opitz.T.summary_of_molecular_genetic_tes_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Variants Detected&#x000a0;<sup>2</sup></th>
                  <th id="hd_h_opitz.T.summary_of_molecular_genetic_tes_1_1_1_4" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Variant Detection Frequency by Test Method&#x000a0;<sup>3</sup></th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_opitz.T.summary_of_molecular_genetic_tes_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">
                    <italic toggle="yes">MID1</italic>
                  </td>
                  <td headers="hd_h_opitz.T.summary_of_molecular_genetic_tes_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>4</sup></td>
                  <td headers="hd_h_opitz.T.summary_of_molecular_genetic_tes_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Sequence variants</td>
                  <td headers="hd_h_opitz.T.summary_of_molecular_genetic_tes_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">15%-50%&#x000a0;<sup>5,&#x000a0;6,&#x000a0;7</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_opitz.T.summary_of_molecular_genetic_tes_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Deletion/duplication analysis&#x000a0;<sup>8</sup></td>
                  <td headers="hd_h_opitz.T.summary_of_molecular_genetic_tes_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">(Multi)exon or whole-gene deletion/duplication</td>
                  <td headers="hd_h_opitz.T.summary_of_molecular_genetic_tes_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Unknown&#x000a0;<sup>9</sup></td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="opitz.TF.1.1">
                <label>1. </label>
                <p>See <related-object source-id="gene" document-id="opitz" object-id="opitz.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein.</p>
              </fn>
              <fn id="opitz.TF.1.2">
                <label>2. </label>
                <p>See <xref ref-type="sec" rid="opitz.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants.</p>
              </fn>
              <fn id="opitz.TF.1.3">
                <label>3. </label>
                <p>The ability of the test method used to detect a variant that is present in the indicated gene</p>
              </fn>
              <fn id="opitz.TF.1.4">
                <label>4. </label>
                <p>Examples of pathogenic variants detected by sequence analysis may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
              </fn>
              <fn id="opitz.TF.1.5">
                <label>5. </label>
                <p>Lack of amplification by PCRs prior to sequence analysis can suggest a putative deletion of one or more exons or the entire X-linked gene in a male; confirmation may require additional testing by deletion/duplication analysis.</p>
              </fn>
              <fn id="opitz.TF.1.6">
                <label>6. </label>
                <p>Includes the variant detection frequency using deletion/duplication analysis</p>
              </fn>
              <fn id="opitz.TF.1.7">
                <label>7. </label>
                <p>Sequence analysis of genomic DNA cannot detect deletion of one or more exons or the entire X-linked gene in a heterozygous female.</p>
              </fn>
              <fn id="opitz.TF.1.8">
                <label>8. </label>
                <p>Testing that identifies exon or whole-gene deletions/duplications not readily detectable by sequence analysis of the coding and flanking intronic regions of genomic DNA; included in the variety of methods that may be used are: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and chromosomal microarray (CMA) that includes this gene/chromosome segment.</p>
              </fn>
              <fn id="opitz.TF.1.9">
                <label>9. </label>
                <p>Three whole-gene deletions have been reported [<xref ref-type="bibr" rid="opitz.REF.winter.2003.249">Winter et al 2003</xref>, <xref ref-type="bibr" rid="opitz.REF.ferrentino.2007.206">Ferrentino et al 2007</xref>, <xref ref-type="bibr" rid="opitz.REF.fontanella.2008.584">Fontanella et al 2008</xref>].</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
        <sec id="opitz.Testing_Strategy">
          <title>Testing Strategy</title>
          <p><bold>To confirm/establish the diagnosis in a proband.</bold> The diagnosis of XLOS is suspected based on clinical features; however, the variable expressivity of the manifestations requires identification of an <italic toggle="yes">MID1</italic> pathogenic variant for confirmation.</p>
          <list list-type="bullet">
            <list-item>
              <p>Sequence analysis of <italic toggle="yes">MID1</italic> is performed first</p>
            </list-item>
            <list-item>
              <p>If a pathogenic variant is not identified, deletion/duplication analysis is considered.</p>
            </list-item>
          </list>
          <p><bold>Carrier testing for at-risk female relatives</bold> requires prior identification of the pathogenic variant in the family.</p>
          <p>Note: (1) Carriers are heterozygotes for this X-linked disorder and may demonstrate hypertelorism or more rarely other clinical findings related to the disorder. (2) Identification of female carriers requires either (a) prior identification of the disease-causing mutation in the family or, (b) if an affected male is not available for testing, molecular genetic testing first by sequence analysis, and then, if no pathogenic variant is identified, by methods to detect gross structural abnormalities.</p>
          <p><bold>Prenatal diagnosis and preimplantation genetic diagnosis (PGD)</bold> for at-risk pregnancies require prior identification of the pathogenic variant in the family.</p>
        </sec>
      </sec>
      <sec id="opitz.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="opitz.Clinical_Description">
          <title>Clinical Description</title>
          <p><bold>Affected males.</bold> X-linked Opitz G/BBB syndrome (XLOS) is characterized by clinical abnormalities of primarily midline structures [<xref ref-type="bibr" rid="opitz.REF.opitz.1969a.95">Opitz et al 1969a</xref>, <xref ref-type="bibr" rid="opitz.REF.opitz.1969b.86">Opitz et al 1969b</xref>]. These defects include facial anomalies, laryngotracheoesophageal (LTE) defects, genitourinary abnormalities, and heart defects. Developmental delay and intellectual disability are common. Wide clinical variability has been described; individuals with a mutated <italic toggle="yes">MID1</italic> allele may manifest only some of the typical clinical signs with different degrees of severity, even among members of the same family.</p>
          <table-wrap id="opitz.T.incidence_of_main_clinical_featu" position="anchor" orientation="portrait">
            <label>Table 2. </label>
            <caption>
              <p>Incidence of Main Clinical Features Seen in Males with XLOS with <italic toggle="yes">MID1</italic> Pathogenic Variants</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_opitz.T.incidence_of_main_clinical_featu_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Finding</th>
                  <th id="hd_h_opitz.T.incidence_of_main_clinical_featu_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Number of Males with Finding / Total Number of Males</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_opitz.T.incidence_of_main_clinical_featu_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Hypertelorism</td>
                  <td headers="hd_h_opitz.T.incidence_of_main_clinical_featu_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">68 / 69</td>
                </tr>
                <tr>
                  <td headers="hd_h_opitz.T.incidence_of_main_clinical_featu_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">CL/P</td>
                  <td headers="hd_h_opitz.T.incidence_of_main_clinical_featu_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">38 / 73</td>
                </tr>
                <tr>
                  <td headers="hd_h_opitz.T.incidence_of_main_clinical_featu_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">LTE defects</td>
                  <td headers="hd_h_opitz.T.incidence_of_main_clinical_featu_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">46 / 73</td>
                </tr>
                <tr>
                  <td headers="hd_h_opitz.T.incidence_of_main_clinical_featu_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Heart defects</td>
                  <td headers="hd_h_opitz.T.incidence_of_main_clinical_featu_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">16 / 73</td>
                </tr>
                <tr>
                  <td headers="hd_h_opitz.T.incidence_of_main_clinical_featu_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Anal defects</td>
                  <td headers="hd_h_opitz.T.incidence_of_main_clinical_featu_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">16 / 73</td>
                </tr>
                <tr>
                  <td headers="hd_h_opitz.T.incidence_of_main_clinical_featu_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Hypospadias</td>
                  <td headers="hd_h_opitz.T.incidence_of_main_clinical_featu_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">63 / 73</td>
                </tr>
                <tr>
                  <td headers="hd_h_opitz.T.incidence_of_main_clinical_featu_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">ID&#x000a0;<sup>1</sup>/developmental delay</td>
                  <td headers="hd_h_opitz.T.incidence_of_main_clinical_featu_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">25 / 73</td>
                </tr>
                <tr>
                  <td headers="hd_h_opitz.T.incidence_of_main_clinical_featu_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Brain abnormalities</td>
                  <td headers="hd_h_opitz.T.incidence_of_main_clinical_featu_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">10 / 25&#x000a0;<sup>2</sup></td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn>
                <p>
                  <xref ref-type="bibr" rid="opitz.REF.fontanella.2008.584">Fontanella et al [2008]</xref>
                </p>
              </fn>
              <fn id="opitz.TF.2.1">
                <label>1. </label>
                <p>Intellectual disability</p>
              </fn>
              <fn id="opitz.TF.2.2">
                <label>2. </label>
                <p>Males with XLOS undergoing MRI examination</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <p><bold>Facial appearance and head anomalies.</bold> The facial appearance of affected males is characterized by ocular hypertelorism, which can also be accompanied by telecanthus, a prominent forehead, widow's peak, broad nasal bridge, anteverted nares, low-set and malformed ears, microcephaly, large fontanelle, and/or prominent metopic suture. Unilateral or bilateral cleft lip and/or palate is present in approximately 50% of affected individuals. Other oral manifestations include high-arched palate, ankyloglossia, micrognathia, hypodontia, and neonatal teeth [<xref ref-type="bibr" rid="opitz.REF.robin.1996.305">Robin et al 1996</xref>, <xref ref-type="bibr" rid="opitz.REF.shaw.2006.185">Shaw et al 2006</xref>, <xref ref-type="bibr" rid="opitz.REF.fontanella.2008.584">Fontanella et al 2008</xref>].</p>
          <p><bold>Urogenital abnormalities.</bold> Hypospadias of varying severity is present in approximately 90% of males with X-linked Opitz G/BBB syndrome and is often associated with other genital anomalies such as cryptorchidism and hypoplastic/bifid scrotum. Severe hypospadias can be associated with urinary tract dysfunction, e.g. vesicoureteric reflux and hydronephrosis [<xref ref-type="bibr" rid="opitz.REF.robin.1996.305">Robin et al 1996</xref>, <xref ref-type="bibr" rid="opitz.REF.pinson.2004.381">Pinson et al 2004</xref>, <xref ref-type="bibr" rid="opitz.REF.fontanella.2008.584">Fontanella et al 2008</xref>, <xref ref-type="bibr" rid="opitz.REF.zhang.2011.348">Zhang et al 2011</xref>].</p>
          <p><bold>Laryngotracheoesophageal (LTE) defects.</bold> LTE abnormalities may result in coughing and choking with feeding, recurrent pneumonia, and life-threatening aspiration. In their most severe form, LTE defects are manifest as laryngeal and tracheoesophageal clefts and in more mild form as tracheoesophageal fistulae or LTE dysmotility. The incidence of respiratory and/or gastroesophageal symptoms is probably underestimated, because mildly affected individuals may only manifest functional swallowing difficulties that improve with age and eventually disappear during infancy [<xref ref-type="bibr" rid="opitz.REF.robin.1996.305">Robin et al 1996</xref>, <xref ref-type="bibr" rid="opitz.REF.de_falco.2003.222">De Falco et al 2003</xref>, <xref ref-type="bibr" rid="opitz.REF.pinson.2004.381">Pinson et al 2004</xref>].</p>
          <p><bold>Neurologic findings.</bold> More than one third of individuals with XLOS show developmental delay and intellectual disability; they frequently manifest delay in onset of walking, short attention span, learning difficulties, and speech problems. In some cases, these delays are secondary to surgical interventions. Midline brain anatomic defects including agenesis or hypoplasia of the corpus callosum and/or cerebellar vermis and Dandy-Walker malformations were identified in 40% of individuals with an <italic toggle="yes">MID1</italic> pathogenic variant who underwent MRI examination [<xref ref-type="bibr" rid="opitz.REF.gaudenz.1998.703">Gaudenz et al 1998</xref>, <xref ref-type="bibr" rid="opitz.REF.cox.2000.2553">Cox et al 2000</xref>, <xref ref-type="bibr" rid="opitz.REF.de_falco.2003.222">De Falco et al 2003</xref>, <xref ref-type="bibr" rid="opitz.REF.winter.2003.249">Winter et al 2003</xref>, <xref ref-type="bibr" rid="opitz.REF.pinson.2004.381">Pinson et al 2004</xref>, <xref ref-type="bibr" rid="opitz.REF.so.2005.1">So et al 2005</xref>, <xref ref-type="bibr" rid="opitz.REF.fontanella.2008.584">Fontanella et al 2008</xref>].</p>
          <p><bold>Other malformations</bold> present in approximately one fifth of individuals with XLOS are congenital heart anomalies (ventricular septal defects, atrial septal defects, coarctation of the aorta, persistent left superior vena cava, patent ductus arteriosus, patent foramen ovale) and anal abnormalities (imperforate or ectopic anus) [<xref ref-type="bibr" rid="opitz.REF.robin.1996.305">Robin et al 1996</xref>, <xref ref-type="bibr" rid="opitz.REF.de_falco.2003.222">De Falco et al 2003</xref>, <xref ref-type="bibr" rid="opitz.REF.pinson.2004.381">Pinson et al 2004</xref>, <xref ref-type="bibr" rid="opitz.REF.fontanella.2008.584">Fontanella et al 2008</xref>].</p>
          <p><bold>Carrier females.</bold> Female carriers usually show only ocular hypertelorism and rarely other manifestations [<xref ref-type="bibr" rid="opitz.REF.robin.1996.305">Robin et al 1996</xref>, <xref ref-type="bibr" rid="opitz.REF.de_falco.2003.222">De Falco et al 2003</xref>, <xref ref-type="bibr" rid="opitz.REF.so.2005.1">So et al 2005</xref>].</p>
        </sec>
        <sec id="opitz.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p>In general no genotype-phenotype correlations have been observed. Pathogenic missense, nonsense, splice site, and frameshift variants, insertions, and deletions all result in highly variable phenotypes even within the same family [<xref ref-type="bibr" rid="opitz.REF.gaudenz.1998.703">Gaudenz et al 1998</xref>, <xref ref-type="bibr" rid="opitz.REF.cox.2000.2553">Cox et al 2000</xref>, <xref ref-type="bibr" rid="opitz.REF.de_falco.2003.222">De Falco et al 2003</xref>, <xref ref-type="bibr" rid="opitz.REF.winter.2003.249">Winter et al 2003</xref>, <xref ref-type="bibr" rid="opitz.REF.pinson.2004.381">Pinson et al 2004</xref>].</p>
          <p>Two possible exceptions are:</p>
          <list list-type="bullet">
            <list-item>
              <p>An association between truncating variants and the presence of anatomic brain abnormalities, in particular cerebellar defects [<xref ref-type="bibr" rid="opitz.REF.fontanella.2008.584">Fontanella et al 2008</xref>];</p>
            </list-item>
            <list-item>
              <p>Possible correlation of a mild phenotype with pathogenic variants in the fibronectin type III domain of the protein [<xref ref-type="bibr" rid="opitz.REF.mnayer.2006.198">Mnayer et al 2006</xref>].</p>
            </list-item>
          </list>
        </sec>
        <sec id="opitz.Penetrance">
          <title>Penetrance</title>
          <p>Usually the presence of an <italic toggle="yes">MID1</italic> pathogenic variant is associated with clinical findings of XLOS; however, recently an instance of reduced penetrance has been reported [<xref ref-type="bibr" rid="opitz.REF.ruiter.2010.195">Ruiter et al 2010</xref>].</p>
        </sec>
        <sec id="opitz.Nomenclature">
          <title>Nomenclature</title>
          <p>Opitz G/BBB syndrome was first reported as two separate entities, BBB syndrome [<xref ref-type="bibr" rid="opitz.REF.opitz.1969b.86">Opitz et al 1969b</xref>] and G syndrome [<xref ref-type="bibr" rid="opitz.REF.opitz.1969a.95">Opitz et al 1969a</xref>]. Subsequently, it has become apparent that the two syndromes identified in 1969 are in fact a single entity, now named Opitz G/BBB syndrome.</p>
          <p>Other names, no longer used, include hypospadias-dysphagia syndrome, Opitz-Frias syndrome, telecanthus with associated abnormalities, and hypertelorism-hypospadias syndrome.</p>
          <p>Of note, X-linked Opitz G/BBB syndrome (XLOS; OSX; type I) is distinct from <related-object link-type="booklink" source-id="gene" document-id="gr_22q11deletion" document-type="chapter">autosomal dominant Opitz G/BBB syndrome</related-object> (ADOS; type II).</p>
        </sec>
        <sec id="opitz.Prevalence">
          <title>Prevalence</title>
          <p>The prevalence of X-linked Opitz G/BBB syndrome ranges from one in 50,000 to one in 100,000 males.</p>
        </sec>
      </sec>
      <sec id="opitz.Genetically_Related_Allelic_Disord">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>No other phenotype is known to be associated with pathogenic variants in <italic toggle="yes">MID1</italic>.</p>
      </sec>
      <sec id="opitz.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p>X-linked Opitz G/BBB syndrome (XLOS; Opitz G/BBB syndrome, type I) and <related-object link-type="booklink" source-id="gene" document-id="gr_22q11deletion" document-type="chapter">autosomal dominant Opitz G/BBB syndrome</related-object> (ADOS; Opitz G/BBB syndrome, type II) (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.omim.org/entry/145410?search=145410&#x00026;highlight=145410">OMIM</ext-link>) share the same clinical picture. ADOS maps to 22q11.2; the gene(s) implicated have not been identified [<xref ref-type="bibr" rid="opitz.REF.robin.1995.459">Robin et al 1995</xref>]. <xref ref-type="bibr" rid="opitz.REF.robin.1996.305">Robin et al [1996]</xref> compared the phenotypic features of the X-linked and autosomal forms of the Opitz syndrome. They found that anteverted nares and posterior pharyngeal cleft were seen only in the X-linked form, but this distinction was questioned by <xref ref-type="bibr" rid="opitz.REF.cox.2000.2553">Cox et al [2000]</xref>. All other manifestations of the syndrome, such as hypertelorism, swallowing difficulties, hypospadias, and developmental delay can be seen in both forms. XLOS and ADOS can be distinguished by the mode of inheritance and by the fact that female carriers of XLOS are asymptomatic or show only ocular hypertelorism, whereas females with ADOS manifest a more complex phenotype [<xref ref-type="bibr" rid="opitz.REF.robin.1995.459">Robin et al 1995</xref>, <xref ref-type="bibr" rid="opitz.REF.robin.1996.305">Robin et al 1996</xref>].</p>
        <p>Frequently, FG syndrome has been misdiagnosed as Opitz syndrome. FG syndrome is also characterized by facial dysmorphism, congenital heart defects, hypospadias, gastroesophageal reflux, and developmental delay/intellectual disability; however, features that distinguish the two conditions include the following findings not observed in Opitz G/BBB syndrome:</p>
        <list list-type="bullet">
          <list-item>
            <p>Congenital hypotonia with joint hyperlaxity that evolves into spasticity</p>
          </list-item>
          <list-item>
            <p>Chronic constipation</p>
          </list-item>
          <list-item>
            <p>Characteristic personality</p>
          </list-item>
        </list>
        <p>FG syndrome is genetically heterogeneous and includes several X-linked forms:</p>
        <list list-type="bullet">
          <list-item>
            <p>FGS1 [<xref ref-type="bibr" rid="opitz.REF.briault.1997.87">Briault et al 1997</xref>, <xref ref-type="bibr" rid="opitz.REF.graham.1998.145">Graham et al 1998</xref>] caused by pathogenic variants in <italic toggle="yes">MED12</italic> (locus [<xref ref-type="bibr" rid="opitz.REF.risheg.2007.451">Risheg et al 2007</xref>]. See <related-object link-type="booklink" source-id="gene" document-id="fg" document-type="chapter"><italic toggle="yes">MED12</italic>-Related Disorders</related-object>.</p>
          </list-item>
          <list-item>
            <p>FGS2 (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.omim.org/entry/300321?search=300321&#x00026;highlight=300321">OMIM</ext-link>) [<xref ref-type="bibr" rid="opitz.REF.briault.1999.112">Briault et al 1999</xref>, <xref ref-type="bibr" rid="opitz.REF.briault.2000.178">Briault et al 2000</xref>] associated with pathogenic variants in <italic toggle="yes">FLNA</italic> (locus Xq28) [<xref ref-type="bibr" rid="opitz.REF.unger.2007.1876">Unger et al 2007</xref>]</p>
          </list-item>
          <list-item>
            <p>FGS3 (linked to Xp22.3) (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.omim.org/entry/300406?search=300406&#x00026;highlight=300406">OMIM</ext-link>) [<xref ref-type="bibr" rid="opitz.REF.dessay.2002.6">Dessay et al 2002</xref>]</p>
          </list-item>
          <list-item>
            <p>FGS4 (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.omim.org/entry/300422?search=300422&#x00026;highlight=300422">OMIM</ext-link>) [<xref ref-type="bibr" rid="opitz.REF.piluso.2003.124">Piluso et al 2003</xref>] caused by pathogenic variants in <italic toggle="yes">CASK</italic> (locus Xp11.4) [<xref ref-type="bibr" rid="opitz.REF.piluso.2009.162">Piluso et al 2009</xref>]</p>
          </list-item>
          <list-item>
            <p>FGS5 (linked to Xq22.3) (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.omim.org/entry/300581?search=300581&#x00026;highlight=300581">OMIM</ext-link>) [<xref ref-type="bibr" rid="opitz.REF.jehee.2005.221">Jehee et al 2005</xref>]</p>
          </list-item>
        </list>
        <p>Other malformation syndromes that share overlapping features with X-linked Opitz G/BBB syndrome:</p>
        <list list-type="bullet">
          <list-item>
            <p>Craniofrontonasal dysplasia (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.omim.org/entry/304110?search=304110&#x00026;highlight=304110">OMIM</ext-link>). In addition to some midline defects in common with Opitz G/BBB syndrome, craniofrontonasal dysplasia has skeletal, skin, nail, and hair defects. A significant proportion of individuals with craniofrontonasal dysplasia have a pathogenic variant in <italic toggle="yes">EFNB1</italic>.</p>
          </list-item>
        </list>
        <p><related-object link-type="booklink" source-id="gene" document-id="mws" document-type="chapter">Mowat-Wilson syndrome</related-object>. Mowat-Wilson syndrome has ocular and gastrointestinal abnormalities that are not usually observed in X-linked Opitz G/BBB syndrome. It is characterized by intellectual disability, microcephaly, distinct facial features, and often Hirschshprung disease. It is caused by a pathogenic variant in <italic toggle="yes">ZEB2</italic>. See also <related-object link-type="booklink" source-id="gene" document-id="hirschsprung-ov" document-type="chapter">Hirschshprung Disease Overview</related-object>.</p>
      </sec>
      <sec id="opitz.Management">
        <title>Management</title>
        <sec id="opitz.Evaluations_Following_Initial_Diag">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease in an individual diagnosed with X-linked Opitz G/BBB syndrome, the following evaluations by a multidisciplinary team (including craniofacial surgeon, ophthalmologist, pediatrician, pediatric urologist, cardiologist, pulmonologist, speech pathologist, and clinical geneticist) are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p>Past medical history and physical examination with attention to head and facial measurements, palate, heart, genitourinary system, and lower respiratory system</p>
            </list-item>
            <list-item>
              <p>Complete eye evaluation including assessment of visual acuity, refractive error, and ocular alignment for possible strabismus</p>
            </list-item>
            <list-item>
              <p>Assessment of hypospadias by a urologist, including ultrasound examination to evaluate for renal/urinary tract abnormalities in males with severe hypospadias</p>
            </list-item>
            <list-item>
              <p>Laryngoscopy and chest x-ray in individuals who have choking with feeding, recurrent pneumonia, and/or aspiration</p>
            </list-item>
            <list-item>
              <p>Assessment of cleft lip/palate (CLP) by a craniofacial surgeon</p>
            </list-item>
            <list-item>
              <p>Age-appropriate assessment of development and intellectual abilities</p>
            </list-item>
            <list-item>
              <p>Assessment of anal position and patency</p>
            </list-item>
            <list-item>
              <p>Echocardiogram</p>
            </list-item>
            <list-item>
              <p>Cranial imaging</p>
            </list-item>
          </list>
        </sec>
        <sec id="opitz.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p>Management of anomalies by a multidisciplinary team (including craniofacial surgeon, ophthalmologist, pediatrician, pediatric urologist, cardiologist, pulmonologist, speech pathologist, and clinical geneticist) to help assure coordination of care is indicated.</p>
          <list list-type="bullet">
            <list-item>
              <p>Treatment as needed by an ophthalmologist</p>
            </list-item>
            <list-item>
              <p>Surgical intervention as needed for hypospadias</p>
            </list-item>
            <list-item>
              <p>Surgical treatment of medically significant laryngotracheoesophageal (LTE) abnormalities; often tracheostomy is necessary initially to assure an adequate airway.</p>
            </list-item>
            <list-item>
              <p>Surgical management for cleft lip/palate and other craniofacial anomalies; therapy for speech problems secondary to the cleft lip and palate</p>
            </list-item>
            <list-item>
              <p>Neuropsychological support; many males with X-linked Opitz G/BBB syndrome require special educational programs.</p>
            </list-item>
            <list-item>
              <p>Surgical intervention for imperforate anus</p>
            </list-item>
            <list-item>
              <p>Surgical repair as needed for heart defects</p>
            </list-item>
          </list>
        </sec>
        <sec id="opitz.Prevention_of_Primary_Manifestatio">
          <title>Prevention of Primary Manifestations</title>
          <p>All primary manifestations are present at birth. To date no factors that can influence their expression have been identified.</p>
        </sec>
        <sec id="opitz.Prevention_of_Secondary_Complicati">
          <title>Prevention of Secondary Complications</title>
          <p>Antireflux pharmacologic therapy minimizes the risk for aspiration until laryngeal competence is assured.</p>
        </sec>
        <sec id="opitz.Surveillance">
          <title>Surveillance</title>
          <p>Regular follow-up depending on the type of malformations present:</p>
          <list list-type="bullet">
            <list-item>
              <p>Craniofacial team follow-up for those with cleft lip/palate, including regular monitoring of hearing</p>
            </list-item>
            <list-item>
              <p>Urology follow-up for those with significant hypospadias and/or renal defects</p>
            </list-item>
            <list-item>
              <p>Cardiac follow-up for those with cardiac defects</p>
            </list-item>
            <list-item>
              <p>Gastroenterology, pulmonary, and/or surgical follow-up for those with LTE defects</p>
            </list-item>
            <list-item>
              <p>Gastroenterology and/or surgical follow-up for those with anal defects</p>
            </list-item>
          </list>
        </sec>
        <sec id="opitz.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>See <xref ref-type="sec" rid="opitz.Related_Genetic_Counseling_Issues">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="opitz.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p>
        </sec>
      </sec>
      <sec id="opitz.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="opitz.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>X-linked Opitz G/BBB syndrome (XLOS) is inherited in an X-linked manner.</p>
        </sec>
        <sec id="opitz.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The father of an affected male will not have the disorder nor will he be a carrier of the pathogenic variant.</p>
            </list-item>
            <list-item>
              <p>In a family with more than one affected individual, the mother of an affected male is an obligate carrier.</p>
            </list-item>
            <list-item>
              <p>If pedigree analysis reveals that the proband is the only affected family member, the mother may be a carrier or the affected male may have a <italic toggle="yes">de novo</italic> pathogenic variant. <italic toggle="yes">De novo</italic> pathogenic variants have been detected in several affected males [<xref ref-type="bibr" rid="opitz.REF.pinson.2004.381">Pinson et al 2004</xref>, <xref ref-type="bibr" rid="opitz.REF.ferrentino.2007.206">Ferrentino et al 2007</xref>, <xref ref-type="bibr" rid="opitz.REF.fontanella.2008.584">Fontanella et al 2008</xref>].</p>
            </list-item>
          </list>
          <p><bold>Sibs of a proband.</bold> The risk to sibs depends on the carrier status of the mother:</p>
          <list list-type="bullet">
            <list-item>
              <p>If the mother of the proband has a pathogenic variant, the chance of transmitting it in each pregnancy is 50%. Male sibs who inherit the pathogenic variant will be affected; female sibs who inherit the pathogenic variant will be carriers and will usually only manifest hypertelorism.</p>
            </list-item>
            <list-item>
              <p>If the pathogenic variant cannot be detected in DNA extracted from the leukocytes of the mother of the only affected male in the family, the risk to sibs is low but greater than that of the general population because of the possibility of germline mosaicism.</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> Mildly affected males will pass the pathogenic variant to all of their daughters and none of their sons.</p>
          <p><bold>Other family members of a proband.</bold> The proband's maternal aunts may be at risk of being carriers and the aunt's offspring, depending on their gender, may be at risk of being carriers or of being affected.</p>
        </sec>
        <sec id="opitz.Carrier_Detection">
          <title>Carrier Detection</title>
          <p>Carrier testing of at-risk female relatives is possible if the pathogenic variant has been identified in the proband.</p>
        </sec>
        <sec id="opitz.Related_Genetic_Counseling_Issues">
          <title>Related Genetic Counseling Issues</title>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk, clarification of carrier status, and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling&#x000a0;(including discussion of potential risks to offspring and reproductive options) to young adults who are affected, are carriers, or are at risk of being carriers.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="opitz.Prenatal_Testing_and_Preimplantati">
          <title>Prenatal Testing and Preimplantation Genetic Diagnosis</title>
          <p>Once the <italic toggle="yes">MID1</italic> pathogenic variant has been identified in an affected family member, prenatal testing and preimplantation genetic diagnosis for a pregnancy at increased risk for XLOS are possible options. Knowing before delivery that a child has XLOS may help families to prepare emotionally and physicians to prepare for the medical needs of a child with birth defects.</p>
        </sec>
      </sec>
      <sec id="opitz.Resources">
        <title>Resources</title>
      </sec>
      <sec id="opitz.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <p><bold>Gene structure.</bold>
<italic toggle="yes">MID1</italic> is composed of nine coding exons and variable and alternative 5' untranslated regions [<xref ref-type="bibr" rid="opitz.REF.quaderi.1997.285">Quaderi et al 1997</xref>, <xref ref-type="bibr" rid="opitz.REF.gaudenz.1998.703">Gaudenz et al 1998</xref>, <xref ref-type="bibr" rid="opitz.REF.perry.1998.299">Perry et al 1998</xref>, <xref ref-type="bibr" rid="opitz.REF.van_den_veyver.1998.251">Van den Veyver et al 1998</xref>, <xref ref-type="bibr" rid="opitz.REF.cox.2000.2553">Cox et al 2000</xref>, <xref ref-type="bibr" rid="opitz.REF.landry.2002.499">Landry &#x00026; Mager 2002</xref>]. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="opitz" object-id="opitz.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
        <p><bold>Benign allelic variants.</bold> Polymorphic variants are not common.</p>
        <p><bold>Pathogenic allelic variants.</bold> To date, pathogenic variants in <italic toggle="yes">MID1</italic> have been found in approximately 80 individuals with X-linked Opitz G/BBB syndrome (XLOS) [<xref ref-type="bibr" rid="opitz.REF.gaudenz.1998.703">Gaudenz et al 1998</xref>, <xref ref-type="bibr" rid="opitz.REF.cox.2000.2553">Cox et al 2000</xref>, <xref ref-type="bibr" rid="opitz.REF.de_falco.2003.222">De Falco et al 2003</xref>, <xref ref-type="bibr" rid="opitz.REF.winter.2003.249">Winter et al 2003</xref>, <xref ref-type="bibr" rid="opitz.REF.pinson.2004.381">Pinson et al 2004</xref>, <xref ref-type="bibr" rid="opitz.REF.so.2005.1">So et al 2005</xref>, <xref ref-type="bibr" rid="opitz.REF.mnayer.2006.198">Mnayer et al 2006</xref>; <xref ref-type="bibr" rid="opitz.REF.ferrentino.2007.206">Ferrentino et al 2007</xref>; <xref ref-type="bibr" rid="opitz.REF.fontanella.2008.584">Fontanella et al 2008</xref>]. No pathogenic variants are recurrent with the exception of p.Arg495Ter, which was identified in five unrelated individuals and p.Arg277Ter, identified in three unrelated individuals. The other pathogenic variants are missense and nonsense variants, small deletions, or insertions located along the entire length of the gene, the majority in the most 3' portion of the gene.</p>
        <p>A duplication of the first coding exon leading to a premature stop codon has been detected in one individual with XLOS [<xref ref-type="bibr" rid="opitz.REF.winter.2003.249">Winter et al 2003</xref>].</p>
        <p>Three whole-gene deletions have been reported [<xref ref-type="bibr" rid="opitz.REF.winter.2003.249">Winter et al 2003</xref>, <xref ref-type="bibr" rid="opitz.REF.ferrentino.2007.206">Ferrentino et al 2007</xref>, <xref ref-type="bibr" rid="opitz.REF.fontanella.2008.584">Fontanella et al 2008</xref>].</p>
        <p><bold>Normal gene product.</bold> The normal gene product is E3 ubiquitin-protein ligase Midline-1, which is anchored to the microtubules [<xref ref-type="bibr" rid="opitz.REF.cainarca.1999.1387">Cainarca et al 1999</xref>, <xref ref-type="bibr" rid="opitz.REF.schweiger.1999.2794">Schweiger et al 1999</xref>, <xref ref-type="bibr" rid="opitz.REF.cox.2000.2553">Cox et al 2000</xref>] and acts as an E3 ubiquitin ligase that regulates the degradation of phosphatase 2A [<xref ref-type="bibr" rid="opitz.REF.liu.2001.6650">Liu et al 2001</xref>, <xref ref-type="bibr" rid="opitz.REF.trockenbacher.2001.287">Trockenbacher et al 2001</xref>, <xref ref-type="bibr" rid="opitz.REF.short.2002.1">Short et al 2002</xref>]. The role of this protein function within the cell and during development is yet to be clarified.</p>
        <p><bold>Abnormal gene product.</bold> The missense and truncated forms lower their affinity for the microtubular apparatus. The pathogenic mechanism is likely to be caused by the loss of E3 ubiquitin-protein ligase Midline-1 function on the microtubules.</p>
      </sec>
      <sec id="opitz.References">
        <title>References</title>
        <sec id="opitz.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="opitz.Literature_Cited.reflist0">
            <ref id="opitz.REF.briault.1997.87">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Briault</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hill</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shrimpton</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhu</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Till</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ronce</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Margaritte-Jeannin</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baraitser</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Middleton-Price</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Malcolm</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thompson</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoo</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilson</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Romano</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guichet</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pembrey</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fontes</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Poustka</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moraine</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>A gene for FG syndrome maps in the Xq12-q21.31 region.</article-title>
                <source>Am J Med Genet</source>
                <volume>73</volume>
                <fpage>87</fpage>
                <lpage>90</lpage>
                <pub-id pub-id-type="pmid">9375929</pub-id>
              </element-citation>
            </ref>
            <ref id="opitz.REF.briault.1999.112">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Briault</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Odent</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lucas</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Le Merrer</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Turleau</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Munnich</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moraine</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Paracentric inversion of the X chromosome [inv(X)(q12q28)] in familial FG syndrome.</article-title>
                <source>Am J Med Genet</source>
                <volume>86</volume>
                <fpage>112</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">10449643</pub-id>
              </element-citation>
            </ref>
            <ref id="opitz.REF.briault.2000.178">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Briault</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Villard</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rogner</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coy</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Odent</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lucas</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Passage</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhu</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shrimpton</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pembrey</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Till</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guichet</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dessay</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fontes</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Poustka</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moraine</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Mapping of X chromosome inversion breakpoints [inv(X)(q11q28)] associated with FG syndrome: a second FG locus</article-title>
                <comment>[FGS2]</comment>
                <source>Am J Med Genet</source>
                <volume>95</volume>
                <fpage>178</fpage>
                <lpage>81</lpage>
                <pub-id pub-id-type="pmid">11078572</pub-id>
              </element-citation>
            </ref>
            <ref id="opitz.REF.cainarca.1999.1387">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cainarca</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Messali</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ballabio</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meroni</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Functional characterization of the Opitz syndrome gene product (midin): evidence for homodimerization and association with microtubules throughout the cell cycle.</article-title>
                <source>Hum Mol Genet</source>
                <volume>8</volume>
                <fpage>1387</fpage>
                <lpage>96</lpage>
                <pub-id pub-id-type="pmid">10400985</pub-id>
              </element-citation>
            </ref>
            <ref id="opitz.REF.cox.2000.2553">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cox</surname>
                    <given-names>TC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Allen</surname>
                    <given-names>LR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cox</surname>
                    <given-names>LL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hopwood</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goodwin</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haan</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suthers</surname>
                    <given-names>GK</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>New mutations in MID1 provide support for loss of function as the cause of X-linked Opitz syndrome.</article-title>
                <source>Hum Mol Genet</source>
                <volume>9</volume>
                <fpage>2553</fpage>
                <lpage>62</lpage>
                <pub-id pub-id-type="pmid">11030761</pub-id>
              </element-citation>
            </ref>
            <ref id="opitz.REF.de_falco.2003.222">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>De Falco</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cainarca</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andolfi</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferrentino</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berti</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rodriguez Criado</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rittinger</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dennis</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Odent</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rastogi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liebelt</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chitayat</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Winter</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jawanda</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ballabio</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Franco</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meroni</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>X-linked Opitz syndrome: novel mutations in the MID1 gene and redefinition of the clinical spectrum.</article-title>
                <source>Am J Med Genet</source>
                <volume>120A</volume>
                <fpage>222</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">12833403</pub-id>
              </element-citation>
            </ref>
            <ref id="opitz.REF.dessay.2002.6">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dessay</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moizard</surname>
                    <given-names>MP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gilardi</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Opitz</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Middleton-Price</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pembrey</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moraine</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Briault</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>FG syndrome: linkage analysis in two families supporting a new gene localization at Xp22.3</article-title>
                <comment>[FGS3]</comment>
                <source>Am J Med Genet</source>
                <volume>112</volume>
                <fpage>6</fpage>
                <lpage>11</lpage>
                <pub-id pub-id-type="pmid">12239712</pub-id>
              </element-citation>
            </ref>
            <ref id="opitz.REF.ferrentino.2007.206">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ferrentino</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bassi</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chitayat</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tabolacci</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meroni</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>MID1 mutation screening in a large cohort of Opitz G/BBB syndrome patients: twenty-nine novel mutations identified.</article-title>
                <source>Hum Mutat</source>
                <volume>28</volume>
                <fpage>206</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">17221865</pub-id>
              </element-citation>
            </ref>
            <ref id="opitz.REF.fontanella.2008.584">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fontanella</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Russolillo</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meroni</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>MID1 mutations in patients with X-linked Opitz G/BBB syndrome.</article-title>
                <source>Hum Mutat.</source>
                <volume>29</volume>
                <fpage>584</fpage>
                <lpage>94</lpage>
                <pub-id pub-id-type="pmid">18360914</pub-id>
              </element-citation>
            </ref>
            <ref id="opitz.REF.gaudenz.1998.703">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gaudenz</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roessler</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Quaderi</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Franco</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Feldman</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gasser</surname>
                    <given-names>DL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wittwer</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Horst</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Montini</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Opitz</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ballabio</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muenke</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Opitz G/BBB syndrome in Xp22: mutations in the MID1 gene cluster in the carboxy-terminal domain.</article-title>
                <source>Am J Hum Genet</source>
                <volume>63</volume>
                <fpage>703</fpage>
                <lpage>10</lpage>
                <pub-id pub-id-type="pmid">9718340</pub-id>
              </element-citation>
            </ref>
            <ref id="opitz.REF.graham.1998.145">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Graham</surname>
                    <given-names>JM</given-names>
                    <suffix>Jr</suffix>
                  </name>
                  <name name-style="western">
                    <surname>Tackels</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dibbern</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Superneau</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rogers</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Corning</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwartz</surname>
                    <given-names>CE</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>FG syndrome: report of three new families with linkage to Xq12-q22.1.</article-title>
                <source>Am J Med Genet</source>
                <volume>80</volume>
                <fpage>145</fpage>
                <lpage>56</lpage>
                <pub-id pub-id-type="pmid">9805132</pub-id>
              </element-citation>
            </ref>
            <ref id="opitz.REF.jehee.2005.221">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jehee</surname>
                    <given-names>FS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosenberg</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krepischi-Santos</surname>
                    <given-names>AC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kok</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Knijnenburg</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Froyen</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vianna-Morgante</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Opitz</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Passos-Bueno</surname>
                    <given-names>MR</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>An Xq22.3 duplication detected by comparative genomic hybridization microarray (Array-CGH) defines a new locus (FGS5) for FG syndrome.</article-title>
                <source>Am J Med Genet A</source>
                <volume>139</volume>
                <fpage>221</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">16283679</pub-id>
              </element-citation>
            </ref>
            <ref id="opitz.REF.landry.2002.499">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Landry</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mager</surname>
                    <given-names>DL</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Widely spaced alternative promoters, conserved between human and rodent, control expression of the Opitz syndrome gene MID1.</article-title>
                <source>Genomics</source>
                <volume>80</volume>
                <fpage>499</fpage>
                <lpage>508</lpage>
                <pub-id pub-id-type="pmid">12408967</pub-id>
              </element-citation>
            </ref>
            <ref id="opitz.REF.liu.2001.6650">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Prickett</surname>
                    <given-names>TD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elliott</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meroni</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brautigan</surname>
                    <given-names>DL</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Phosphorylation and microtubule association of the Opitz syndrome protein mid-1 is regulated by protein phosphatase 2A via binding to the regulatory subunit alpha 4.</article-title>
                <source>Proc Natl Acad Sci U S A</source>
                <volume>98</volume>
                <fpage>6650</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">11371618</pub-id>
              </element-citation>
            </ref>
            <ref id="opitz.REF.mnayer.2006.198">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mnayer</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Khuri</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Merheby</surname>
                    <given-names>HA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meroni</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elsas</surname>
                    <given-names>LJ</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>A structure-function study of MID1 mutations associated with a mild Opitz phenotype.</article-title>
                <source>Mol Genet Metab</source>
                <volume>87</volume>
                <fpage>198</fpage>
                <lpage>203</lpage>
                <pub-id pub-id-type="pmid">16378742</pub-id>
              </element-citation>
            </ref>
            <ref id="opitz.REF.opitz.1969a.95">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Opitz</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frias</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gutenberger</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pellet</surname>
                    <given-names>JR</given-names>
                  </name>
                </person-group>
                <year>1969a</year>
                <article-title>The G syndrome of multiple congenital anomalies.</article-title>
                <source>Birth defects: Original Article Series</source>
                <issue>V</issue>
                <volume>2</volume>
                <fpage>95</fpage>
                <lpage>102</lpage>
              </element-citation>
            </ref>
            <ref id="opitz.REF.opitz.1969b.86">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Opitz</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Summitt</surname>
                    <given-names>RL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>DW</given-names>
                  </name>
                </person-group>
                <year>1969b</year>
                <article-title>The BBB syndrome familial telecanthus with associated congenital anomalies.</article-title>
                <source>Birth Defects: Original Article Series</source>
                <issue>V</issue>
                <volume>2</volume>
                <fpage>86</fpage>
                <lpage>94</lpage>
              </element-citation>
            </ref>
            <ref id="opitz.REF.perry.1998.299">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Perry</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Feather</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Palmer</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ashworth</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>The human FXY gene is located within Xp22.3: implications for evolution of the mammalian X chromosome.</article-title>
                <source>Hum Mol Genet</source>
                <volume>7</volume>
                <fpage>299</fpage>
                <lpage>305</lpage>
                <pub-id pub-id-type="pmid">9425238</pub-id>
              </element-citation>
            </ref>
            <ref id="opitz.REF.piluso.2003.124">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Piluso</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carella</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>D'Avanzo</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Santinelli</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carrano</surname>
                    <given-names>EM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>D'Avanzo</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>D'Adamo</surname>
                    <given-names>AP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gasparini</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nigro</surname>
                    <given-names>V</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Genetic heterogeneity of FG syndrome: a fourth locus (FGS4) maps to Xp11.4-p11.3 in an Italian family.</article-title>
                <source>Hum Genet</source>
                <volume>112</volume>
                <fpage>124</fpage>
                <lpage>30</lpage>
                <pub-id pub-id-type="pmid">12522552</pub-id>
              </element-citation>
            </ref>
            <ref id="opitz.REF.piluso.2009.162">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Piluso</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>D'Amico</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saccone</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bismuto</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rotundo</surname>
                    <given-names>IL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Di Domenico</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aurino</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwartz</surname>
                    <given-names>CE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neri</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nigro</surname>
                    <given-names>V</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>A missense mutation in CASK causes FG syndrome in an Italian family.</article-title>
                <source>Am J Hum Genet.</source>
                <volume>84</volume>
                <fpage>162</fpage>
                <lpage>77</lpage>
                <pub-id pub-id-type="pmid">19200522</pub-id>
              </element-citation>
            </ref>
            <ref id="opitz.REF.pinson.2004.381">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pinson</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Auge</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Audollent</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mattei</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Etchevers</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gigarel</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Razavi</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lacombe</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Odent</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Le Merrer</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Amiel</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Munnich</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meroni</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lyonnet</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vekemans</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Attie-Bitach</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Embryonic expression of the human MID1 gene and its mutations in Opitz syndrome.</article-title>
                <source>J Med Genet</source>
                <volume>41</volume>
                <fpage>381</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">15121778</pub-id>
              </element-citation>
            </ref>
            <ref id="opitz.REF.quaderi.1997.285">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Quaderi</surname>
                    <given-names>NA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schweiger</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gaudenz</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Franco</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rugarli</surname>
                    <given-names>EI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berger</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Feldman</surname>
                    <given-names>GJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Volta</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andolfi</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gilgenkrantz</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marion</surname>
                    <given-names>RW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hennekam</surname>
                    <given-names>RC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Opitz</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muenke</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ropers</surname>
                    <given-names>HH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ballabio</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>Opitz G/BBB syndrome, a defect of midline development, is due to mutations in a new RING finger gene on Xp22.</article-title>
                <source>Nat Genet</source>
                <volume>17</volume>
                <fpage>285</fpage>
                <lpage>91</lpage>
                <pub-id pub-id-type="pmid">9354791</pub-id>
              </element-citation>
            </ref>
            <ref id="opitz.REF.risheg.2007.451">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Risheg</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Graham</surname>
                    <given-names>JM</given-names>
                    <suffix>Jr</suffix>
                  </name>
                  <name name-style="western">
                    <surname>Clark</surname>
                    <given-names>RD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rogers</surname>
                    <given-names>RC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Opitz</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moeschler</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peiffer</surname>
                    <given-names>AP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>May</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Joseph</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jones</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stevenson</surname>
                    <given-names>RE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwartz</surname>
                    <given-names>CE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Friez</surname>
                    <given-names>MJ</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>A recurrent mutation in MED12 leading to R961W causes Opitz-Kaveggia syndrome.</article-title>
                <source>Nat Genet.</source>
                <volume>39</volume>
                <fpage>451</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">17334363</pub-id>
              </element-citation>
            </ref>
            <ref id="opitz.REF.robin.1995.459">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Robin</surname>
                    <given-names>NH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Feldman</surname>
                    <given-names>GJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aronson</surname>
                    <given-names>AL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mitchell</surname>
                    <given-names>HF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weksberg</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leonard</surname>
                    <given-names>CO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burton</surname>
                    <given-names>BK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Josephson</surname>
                    <given-names>KD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laxov&#x000e1;</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aleck</surname>
                    <given-names>KA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Allanson</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guion-Almeida</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martin</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leichtman</surname>
                    <given-names>LG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Price</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Opitz</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muenke</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>1995</year>
                <article-title>Opitz syndrome is genetically heterogeneous, with one locus on Xp22, and a second locus on 22q11.2.</article-title>
                <source>Nat Genet.</source>
                <volume>11</volume>
                <fpage>459</fpage>
                <lpage>61</lpage>
                <pub-id pub-id-type="pmid">7493033</pub-id>
              </element-citation>
            </ref>
            <ref id="opitz.REF.robin.1996.305">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Robin</surname>
                    <given-names>NH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Opitz</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muenke</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>1996</year>
                <article-title>Opitz G/BBB syndrome: clinical comparisons of families linked to Xp22 and 22q, and a review of the literature.</article-title>
                <source>Am J Med Genet</source>
                <volume>62</volume>
                <fpage>305</fpage>
                <lpage>17</lpage>
                <pub-id pub-id-type="pmid">8882794</pub-id>
              </element-citation>
            </ref>
            <ref id="opitz.REF.ruiter.2010.195">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ruiter</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kamsteeg</surname>
                    <given-names>EJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meroni</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Vries</surname>
                    <given-names>BB</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>A MID1 mutation associated with reduced penetrance of X-linked Opitz G/BBB syndrome.</article-title>
                <source>Clin Dysmorphol.</source>
                <volume>19</volume>
                <fpage>195</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">20671548</pub-id>
              </element-citation>
            </ref>
            <ref id="opitz.REF.schweiger.1999.2794">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Schweiger</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Foerster</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lehmann</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suckow</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muller</surname>
                    <given-names>YA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walter</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davies</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Porter</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Bokhoven</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lunt</surname>
                    <given-names>PW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Traub</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ropers</surname>
                    <given-names>HH</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>The Opitz syndrome gene product, MID1, associates with microtubules.</article-title>
                <source>Proc Natl Acad Sci U S A</source>
                <volume>96</volume>
                <fpage>2794</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">10077590</pub-id>
              </element-citation>
            </ref>
            <ref id="opitz.REF.shaw.2006.185">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Shaw</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Longman</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Irving</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Splitt</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Neonatal teeth in X-linked Opitz (G/BBB) syndrome.</article-title>
                <source>Clin Dysmorphol</source>
                <volume>15</volume>
                <fpage>185</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">16760742</pub-id>
              </element-citation>
            </ref>
            <ref id="opitz.REF.short.2002.1">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Short</surname>
                    <given-names>KM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hopwood</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yi</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cox</surname>
                    <given-names>TC</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>MID1 and MID2 homo- and heterodimerise to tether the rapamycin-sensitive PP2A regulatory subunit, Alpha 4, to microtubules: implications for the clinical variability of X-linked Opitz GBBB syndrome and other developmental disorders.</article-title>
                <source>BMC Cell Biol</source>
                <volume>3</volume>
                <fpage>1</fpage>
                <pub-id pub-id-type="pmid">11806752</pub-id>
              </element-citation>
            </ref>
            <ref id="opitz.REF.so.2005.1">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>So</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suckow</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kijas</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kalscheuer</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moser</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Winter</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baars</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Firth</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lunt</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hamel</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meinecke</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moraine</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Odent</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schinzel</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Smagt</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Devriendt</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Albrecht</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gillessen-Kaesbach</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Burgt</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Petrij</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Faivre</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McGaughran</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McKenzie</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Opitz</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cox</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schweiger</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Mild phenotypes in a series of patients with Opitz GBBB syndrome with MID1 mutations.</article-title>
                <source>Am J Med Genet A.</source>
                <volume>132A</volume>
                <fpage>1</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">15558842</pub-id>
              </element-citation>
            </ref>
            <ref id="opitz.REF.trockenbacher.2001.287">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Trockenbacher</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suckow</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Foerster</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Winter</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krauss</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ropers</surname>
                    <given-names>HH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schneider</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schweiger</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>MID1, mutated in Opitz syndrome, encodes an ubiquitin ligase that targets phosphatase 2A for degradation.</article-title>
                <source>Nat Genet</source>
                <volume>29</volume>
                <fpage>287</fpage>
                <lpage>94</lpage>
                <pub-id pub-id-type="pmid">11685209</pub-id>
              </element-citation>
            </ref>
            <ref id="opitz.REF.unger.2007.1876">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Unger</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mainberger</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spitz</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>B&#x000e4;hr</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zeschnigk</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zabel</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Superti-Furga</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morris-Rosendahl</surname>
                    <given-names>DJ</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Filamin A mutation is one cause of FG syndrome.</article-title>
                <source>Am J Med Genet A.</source>
                <volume>143A</volume>
                <fpage>1876</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">17632775</pub-id>
              </element-citation>
            </ref>
            <ref id="opitz.REF.van_den_veyver.1998.251">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Van den Veyver</surname>
                    <given-names>IB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cormier</surname>
                    <given-names>TA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jurecic</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baldini</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zoghbi</surname>
                    <given-names>HY</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Characterization and physical mapping in human and mouse of a novel RING finger gene in Xp22.</article-title>
                <source>Genomics</source>
                <volume>51</volume>
                <fpage>251</fpage>
                <lpage>61</lpage>
                <pub-id pub-id-type="pmid">9722948</pub-id>
              </element-citation>
            </ref>
            <ref id="opitz.REF.winter.2003.249">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Winter</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lehmann</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suckow</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kijas</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kulozik</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kalscheuer</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hamel</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Devriendt</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Opitz</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lenzner</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ropers</surname>
                    <given-names>HH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schweiger</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Duplication of the MID1 first exon in a patient with Opitz G/BBB syndrome.</article-title>
                <source>Hum Genet</source>
                <volume>112</volume>
                <fpage>249</fpage>
                <lpage>54</lpage>
                <pub-id pub-id-type="pmid">12545276</pub-id>
              </element-citation>
            </ref>
            <ref id="opitz.REF.zhang.2011.348">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhao</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Markljung</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nordenskj&#x000f6;ld</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Hypospadias associated with hypertelorism, the mildest phenotype of Opitz syndrome.</article-title>
                <source>J Hum Genet.</source>
                <volume>56</volume>
                <fpage>348</fpage>
                <lpage>51</lpage>
                <pub-id pub-id-type="pmid">21326312</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="opitz.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="opitz.Author_Notes">
          <title>Author Notes</title>
          <p>Basic research on the molecular basis of X-linked Opitz syndrome, functional study of <italic toggle="yes">MID1</italic> and proteins belonging to the TRIM/RBCC family.</p>
        </sec>
        <sec id="opitz.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>28 July 2011 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>20 June 2007 (cd) Revision: deletion/duplication analysis available clinically</p>
            </list-item>
            <list-item>
              <p>18 January 2007 (me) Comprehensive update posted to live Web site</p>
            </list-item>
            <list-item>
              <p>17 December 2004 (me) Review posted to live Web site</p>
            </list-item>
            <list-item>
              <p>30 June 2004 (gm) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
